Consumers Would Benefit from State Bans on Copay Adjustment Programs ByNate Scherer April 27, 2022February 28, 2024
Real Clear Policy: Are ‘Affordability Boards’ the Answer to Increasing Drug Prices? ByKrisztina Pusok February 17, 2020
The Hill: Competition, Not Capping Increases, is the Cure for High Drug Prices ByOliver McPherson-Smith January 23, 2020January 23, 2020
Real Clear Health: Rx Price Transparency Is Key to Lowering Health Care Costs ByOliver McPherson-Smith January 10, 2020February 28, 2024
ACI Joins Coalition in Opposition to the Pelosi Drug Tax Pan BySteve Pociask October 15, 2019October 15, 2019
Latest ConsumerGram: Lowering Drug Prices in Maryland Means Bringing Transparency to PBMs ByKrisztina Pusok March 4, 2019
Inside Sources: Pharmacy Benefit Managers Pad Their Profits at Your Expense ByLiam Sigaud December 11, 2018
